A new approach on methamphetamine-induced hepatotoxicity: involvement of mitochondrial dysfunction

References

• Albertson TE, Derlet RW, Van Hoozen BE. (1999). Methamphetamine and the expanding complications of amphetamines. West J Med 170:214–19
   PubMedGoogle Scholar
• Andersson BS, Aw TY, Jones DP. (1987). Mitochondrial transmembrane potential and pH gradient during anoxia. Am J Physiol 252:C349–55
   PubMed Web of Science ®Google Scholar
• Baba T, Yamada H, Oguri K, Yoshimura H. (1988). Participation of cytochrome P-450 isozymes in N-demethylation, N-hydroxylation and aromatic hydroxylation of methamphetamine. Xenobiotica 18:475–84
   PubMed Web of Science ®Google Scholar
• Benzie IFF. (1996). Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 47:233–61
   PubMed Web of Science ®Google Scholar
• Borutaite V. (2010). Mitochondria as decision-makers in cell death. Environ Mol Mutagen 51:406–16
   PubMed Web of Science ®Google Scholar
• Brecht ML, Lovinger K, Herbeck DM, Urada D. (2013). Patterns of treatment utilization and methamphetamine use during first 10 years after methamphetamine initiation. J Subst Abuse Treat 44:548–56
   PubMed Web of Science ®Google Scholar
• Caldwell J, Dring LG, Williams RT. (1972). Metabolism of (14 C) methamphetamine in man, the guinea pig and the rat. Biochem J 129:11–22
   PubMed Web of Science ®Google Scholar
• Cole SP, Deeley RG. (2006). Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol Sci 27:438–46
   PubMed Web of Science ®Google Scholar
• Cruickshank CC, Dyer KR. (2009). A review of the clinical pharmacology of methamphetamine. Addiction 104:1085–99
   PubMed Web of Science ®Google Scholar
• Dahshan A. (2009). Prenatal exposure to methamphetamine presenting as neonatal cholestasis. J Clin Gastroenterol 43:88–90
   PubMedGoogle Scholar
• Derlet RW, Heischober B. (1990). Methamphetamine stimulant of the 1990s? West J Med 153:625–8
   PubMedGoogle Scholar
• Dostalek M, Jurica J, Pistovcakova J, et al. (2007). Effect of methamphetamine on cytochrome P450 activity. Xenobiotica 37:1355–66
   PubMed Web of Science ®Google Scholar
• Eskandari MR, Fard JK, Hosseini MJ, Pourahmad J. (2012). Glutathione mediated reductive activation and mitochondrial dysfunction play key roles in lithium induced oxidative stress and cytotoxicity in liver. Biometals 25:863–73
   PubMed Web of Science ®Google Scholar
• Galati G, Teng S, Moridani MY, et al. (2000). Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol Drug Interact 17:311–49
   PubMedGoogle Scholar
• Gogvadze V, Orrenius S, Zhivotovsky B. (2006). Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochimica et Biophysica Acta 1757:639–47
   PubMed Web of Science ®Google Scholar
• Hissin J, Hilf R. (1976). A fluorometric method for determination of oxidised and reduced glutathione in tissues. Anal Biochem 74:214–26
   PubMed Web of Science ®Google Scholar
• Kamijo Y, Soma K, Nishida M, et al. (2002). Acute liver failure following intravenous methamphetamine. Vet Hum Toxicol 44:216–7
   PubMedGoogle Scholar
• Karch SB, Stephens BG, Ho CH. (1999). Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 44:359–68
   PubMed Web of Science ®Google Scholar
• Keppler D. (1999). Export pumps for glutathione S-conjugates. Free Radic Biol Med 27:985–91
   PubMed Web of Science ®Google Scholar
• Kipke MD, O'Connor S, Palmer R, MacKenzie RG. (1995). Street youth in Los Angeles. Profile of a group at high risk for human immunodeficiency virus infection. Arch Pediatr Adolesc Med 149:513–51
   PubMed Web of Science ®Google Scholar
• Koriem KM, Abdelhamid AZ, Younes HF. (2013). Caffeic acid protects tissue antioxidants and DNA content in methamphetamine induced tissue toxicity in SD rats. Toxicol Mech Methods 23:134–43
   PubMed Web of Science ®Google Scholar
• Kushnareva Y, Newmeyer DD. (2010). Bioenergetics and cell death. Ann N Y Acad Sci 1201:50–7
   PubMed Web of Science ®Google Scholar
• Kuwayama K, Tsujikawa K, Miyaguchi H, et al. (2009). Determination of 4-hydroxy-3-methoxymethamphetamine as a metabolite of methamphetamine in rats and human liver microsomes using gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. J Anal Toxicol 33:266–71
   PubMedGoogle Scholar
• Lin LY, Di Stefano EW, Schmitz DA, et al. (1997). Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos 25:1059–64
   PubMed Web of Science ®Google Scholar
• Moldeus P, Hogberg J, Orrenius S. (1978). Isolation and use of liver cells. Meth Enzymol 52:60–71
   PubMedGoogle Scholar
• Mooney LJ, Glasner-Edwards S, Rawson RA, Ling W. (2009). Medical effects of methamphetamine use. In: Roll JM, Rawson RA, Ling W, et al., eds. Methamphetamine addiction: from basic science to treatment. New York: Guilford, 117–42
   Google Scholar
• Nakagawa T, Kaneko S. (2008). Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy). J Pharmacol Sci 106:2–8
   PubMedGoogle Scholar
• O'Brien PJ, Siraki AG. (2005). Accelerated cytotoxicity mechanism screening using drug metabolising enzyme modulators. Curr Drug Metab 6:101–9
   PubMed Web of Science ®Google Scholar
• Orrenius S, Nicotera P, Zhivotovsky B. (2011). Cell death mechanisms and their implications in toxicology. Toxicol Sci 119:3–19
   PubMed Web of Science ®Google Scholar
• Pompella A, Visvikis A, Paolicchi A, et al. (2003). The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66:1499–503
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Eskandari MR, Daraei B. (2010a). A comparison of hepatocyte cytotoxic mechanisms for thallium (I) and thallium (III). Environ Toxicol 25:456–67
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Eskandari MR, Nosrati M, et al. (2010b). Involvement of mitochondrial/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition. Eur J Pharmacol 643:162–9
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Hosseini MJ, Eskandari MR, et al. (2010c). Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity. Xenobiotica 40:763–71
   PubMed Web of Science ®Google Scholar
• Pourahmad J, O’Brien PJ. (2000). A comparison of hepatocyte cytotoxic mechanisms for Cu2+ and Cd2+. Toxicology 143:263–73
   PubMed Web of Science ®Google Scholar
• Roberts SM, Harbison RD, James RC. (1994). Methamphetamine potentiation of carbon tetrachloride hepatotoxicity in mice. J Pharmacol Exp Ther 271:1051–7
   PubMed Web of Science ®Google Scholar
• Roberts SM, Harbison RD, James RC. (1995). Mechanistic studies on the potentiation of carbon tetrachloride hepatotoxicity by methamphetamine. Toxicology 97:49–57
   PubMed Web of Science ®Google Scholar
• Smith MT, Thor H, Hartzell P, Orrenius S. (1982). The measurement of lipid peroxidation in isolated hepatocytes. Biochem Pharmacol 31:19–26
   PubMed Web of Science ®Google Scholar
• Tang W. (2007). Drug metabolite profiling and elucidation of drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 3:407–20
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. (2007). World drug report volume 1. Analysis. Vienna: United Nations Office on Drugs and Crime
   Google Scholar
• Valko M, Leibfritz D, Moncol J, et al. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84
   PubMed Web of Science ®Google Scholar
• Volkow ND, Fowler JS, Wang GJ, et al. (2010). Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. PLoS One 5:e15269
   PubMed Web of Science ®Google Scholar
• Yamada H, Baba T, Hirata Y, et al. (1984). Studies on N-demethylation of methamphetamine by liver microsomes of guinea-pigs and rats: the role of flavin-containing mono-oxygenase and cytochrome P-450 systems. Xenobiotica 14:861–6
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Takano R, Egashira T, Yamanaka Y. (1984). Metabolism of methamphetamine, amphetamine and p-hydroxymethamphetamine by rat-liver microsomal preparations in vitro. Xenobiotica 14:867–75
   PubMed Web of Science ®Google Scholar